Premium
Edesa Biotech Inc (EDSA)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-i... Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients. Show more
TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.13 | 7.69230769231 | 1.69 | 2.4 | 1.65 | 99270 | 2.20486865 | CS |
| 4 | -0.03 | -1.62162162162 | 1.85 | 2.4 | 1.56 | 31567 | 2.02455059 | CS |
| 12 | -0.84 | -31.5789473684 | 2.66 | 2.9699 | 1.55 | 30699 | 2.13639565 | CS |
| 26 | -3.63 | -66.6055045872 | 5.45 | 5.45 | 1.55 | 22733 | 2.81491211 | CS |
| 52 | -3.07 | -62.7811860941 | 4.89 | 5.99 | 1.55 | 16819 | 3.42339771 | CS |
| 156 | -26.88 | -93.6585365854 | 28.7 | 31.85 | 1.55 | 101917 | 10.0003491 | CS |
| 260 | -19.39 | -91.4191419142 | 21.21 | 133.7 | 1.55 | 385225 | 54.2911295 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
